Yale Liver Cancer Symposium 2019

liver image

Yale Liver Cancer Symposium 2019: The Changing Landscape of Hepatocellular Carcinoma (HCC) Management


Yale West Campus
Friday, March 1, 2019
7:30am - 5:00pm

Course Director: 
Mario Strazzabosco, MD, PhD, Clinical Program Leader, Smilow Cancer Hospital Liver Cancer Program

For information please call (203) 785-2229. To register, click here 


Agenda: 


7:30 am Registration and Breakfast

8:00 Opening Remarks
Lori Pickens, MPH, Senior Vice President and Executive Director, Smilow Cancer Hospital

8:15 Session One: The Changing Landscape of Hepatocellular

Carcinoma (HCC) Management—Between Reality and Predictions
Moderators: Mario Strazzabosco, MD, PhD, Professor of Medicine; Clinical Program Leader, Liver Cancer Program; Deputy Director, Yale Liver Center
Rob Goodman , MBBCh, MBA, BMSc, Chairman and Professor of Radiology and Biomedical Imaging

Epidemiology Trends: Evolving Etiologies, Risk Factors, the Impact of Obesity, and Screening Guidelines for Populations at Risk
Tamar Taddei, MD, Associate Professor of Medicine (Digestive Diseases)

HCC Imaging: Diagnostic Paradigms, Reporting, and New Tools
and Biomedical Imaging

Big Data: Artificial Intelligence Solutions for Decision Making
Julius Chapiro, MD, Associate Research Scientist, Radiology and
Biomedical Imaging

The Expanding Role of Biopsy and Genomic Sequencing in the Age of Personalized Therapies
Dhanpat Jain, MD, Professor of Pathology and of Medicine (Digestive Diseases)

Q&A

10:15 Break

10:25 Targeted Medical Treatment for HCC—Present Options and What’s New in the Pipeline
Stacey Stein, MD, Assistant Professor of Medicine (Medical Oncology)

Q&A

10:55 Session Two: The Patient With Early Stage Disease:What is the First Line Therapy?

Moderator: Nita Ahuja, MD, MBA, Chair, Department of Surgery; William H. Carmalt Professor of Surgery

Niches for Stereotactic Radiation Therapy
Kimberly Johung, MD, PhD, Assistant Professor of Therapeutic Radiology; Director, Gastrointestinal Radiotherapy Program

Surgical Resection
Charles Cha, MD, FACS, Associate Professor of Surgery (Oncology and Gastrointestinal)

Image-guided Ablation
Jeffrey Pollak, MD, Robert I. White, Jr., Professor of Radiology and Biomedical Imaging

How does Transplant Fit in?
Michael Schilsky, MD, Professor of Medicine (Digestive Diseases);
Medical Director, Adult Liver Transplant Center

The Case for Robotic Surgery
David Mulligan, MD, FACS, Professor of Surgery (Transplant); Section Chief, Transplantation Surgery and Immunology

Q&A

1:00 pm Lunch

2:00 Session Three: The Patient With Intermediate Stage Disease: New Frontiers

Moderator: Sukru Emre, MD, Professor of Surgery (Transplant) and of Pediatrics

State-of-the-Art Transarterial Chemoembolization—30 Years of TACE
Kevin Kim, MD, Professor of Radiology and Biomedical Imaging; Professor of Medicine (Medical Oncology)

10 Years of Clinical Trials
Todd Schlachter, MD, Assistant Professor, Radiology and Biomedical Imaging

Q&A

3:20 Break

3:40 Session Four: The Patient with Advanced Stage Disease

Michael Nathanson, MD, PhD, Gladys Phillips Crofoot Professor of Medicine (Digestive Diseases); Professor of Cell Biology; Director, Yale Liver Center

Role of TARE Y90—Lessons Learned
Juan Carlos Perez Lozada, MD, Assistant Professor of Radiology and Biomedical Imaging

Palliative Care: Support for Patients and Families Facing Advanced Liver Disease
Andrew Putnam, MD, Assistant Professor of Medicine; Smilow Cancer Hospital Palliative Care Program

Q&A

4:40 Putting it all Together



5:00 Conclude